X hits on this document

Powerpoint document

Clevidipine Phase III Studies: Perioperative Hypertension - page 14 / 65

187 views

0 shares

0 downloads

0 comments

14 / 65

Endpoints

Primary*- Cumulative rate of clinical outcomes at 30 days:

Death

MI: symptomatic presentation, enzyme release, &/or new ECG changes

Stroke: Hemorrhagic or ischemic

Renal Dysfunction: Serum creatinine ≥ 2.0 mg/dL with an increase of ≥ 0.7 mg/dL from pre- to post-op

Secondary

SAEs through day 7

BP control during the first 24 h

* Blinded CEC adjudication of all primary measures

Aronson S et al. Anesth Analg 2008 (in press)

Document info
Document views187
Page views187
Page last viewedWed Dec 07 00:31:20 UTC 2016
Pages65
Paragraphs1351
Words4734

Comments